Eight Years' Experience With High-Intensity Focused Ultrasonography for Treatment of Localized Prostate Cancer

Urology

Volumn 72, Issue 6, 2008, Pages 1329-1333

  Blana, Andreas ^a   Rogenhofer, Sebastian ^a   Ganzer, Roman ^a   Lunz, Jens Claudio ^a   Schostak, Martin ^b   Wieland, Wolf F ^a   Walter, Bernhard ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER NECK STENOSIS; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FOLLOW UP; GLEASON SCORE; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; HUMAN TISSUE; INCONTINENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SALVAGE THERAPY; TREATMENT FAILURE; TREATMENT OUTCOME; URINARY TRACT INFECTION;

AGED; BIOPSY; DISEASE-FREE SURVIVAL; HUMANS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS; RECURRENCE; SALVAGE THERAPY; TREATMENT OUTCOME; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 56449120244     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.06.062     Document Type: Article

References (20)

1. Blana A., Walter B., Rogenhofer S., et al. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Urology 63 (2004) 297-300
2. Roach III M., Hanks G., Thames Jr. H., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65 (2006) 965-974
3. Madersbacher S., Pedevilla M., Vingers L., et al. Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res 55 (1995) 3346-3351
4. Gelet A., Chapelon J.Y., Bouvier R., et al. Treatment of prostate cancer with transrectal focused ultrasound: Early clinical experience. Eur Urol 29 (1996) 174-183
5. Poissonnier L., Chapelon J.Y., Rouviere O., et al. Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol 51 (2007) 381-387
6. Uchida T., Illing R.O., Cathcart P.J., et al. To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate?. BJU Int 98 (2006) 537-539
7. Chaussy C.G., and Thuroff S. High-intensive focused ultrasound in localized prostate cancer. J Endourol 14 (2000) 293-299
8. Amling C.L., Bergstralh E.J., Blute M.L., et al. Defining prostate specific antigen progression after radical prostatectomy: What is the most appropriate cut point?. J Urol 165 (2001) 1146-1151
9. Uchida T., Ohkusa H., Yamashita H., et al. Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer. Int J Urol 13 (2006) 228-233
10. Bahn D.K., Lee F., Badalament R., et al. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 60 suppl 1 (2002) 3-11
11. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era. Cancer 95 (2002) 281-286
12. Kupelian P., Kuban D., Thames H., et al. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: The combined experience of nine institutions in patients treated in 1994 and 1995. Int J Radiat Oncol Biol Phys 61 (2005) 415-419
13. Kupelian P.A., Willoughby T.R., Reddy C.A., et al. Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience. Int J Radiat Oncol Biol Phys 68 (2007) 1424-1430
14. Zelefsky M.J., Kuban D.A., Levy L.B., et al. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys 67 (2007) 327-333
15. Rewcastle J.C. High intensity focused ultrasound for prostate cancer: A review of the scientific foundation, technology and clinical outcomes. Technol Cancer Res Treat 5 (2006) 619-625
16. Chavrier F., Chapelon J.Y., Gelet A., et al. Modeling of high-intensity focused ultrasound-induced lesions in the presence of cavitation bubbles. J Acoust Soc Am 108 (2000) 432-440
17. Chaussy C., and Thuroff S. The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr Urol Rep 4 (2003) 248-252
18. Vallancien G., Prapotnich D., Cathelineau X., et al. Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: Feasibility study. J Urol 171 6 Pt 1 (2004) 2265-2267
19. Wei J.T., Dunn R.L., Marcovich R., et al. Prospective assessment of patient reported urinary continence after radical prostatectomy. J Urol 164 3 Pt 1 (2000) 744-748
20. Frank S.J., Pisters L.L., Davis J., et al. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J Urol 177 (2007) 2151-2156